CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 890 enrolled
Drug / intervention
Melectis Gdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02485860
NCT02485860Phase 4Completed

Interest in the Use of Dressings With Honey for Wound Healing After Excision of Pilonidal Cyst

Centre Hospitalier Departemental Vendee·interventional·Posted Jun 30, 2015·Updated Dec 2, 2025

In Brief

A Phase 4 clinical trial evaluating Melectis G for Pilonidal Cysts. Completed, enrolled 890 participants across 1 site.

Detailed Summary

The management of pilonidal cysts is a skin excision and under deep skin. Scarring requires regular dressings (daily for 15 days and then every 48 hours) until complete healing. This healing is obtained on average in 68 days. Some patients have difficulties in healing with a final healing achieved on average in 95 days. Some teams use honey to promote wound cavitary wounds (wound infection, pressure ulcers, varicose wound). The acceleration of wound healing is due to antibacterial properties and hyperosmolarity to reduce secretions. ) The use of honey in pilonidal cysts is not evaluated and may accelerate healing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPilonidal Cysts
CountriesFrance
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 30, 2015
Enrollment StartMar 8, 2016
Primary CompletionFeb 10, 2022
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 11.0 years ago

Interventions

Melectis Gdevice